Single cell dark matter in the context of HIV and substance use
- Institution
- FEINSTEIN INSTITUTE FOR MEDICAL RESEARCH, NY
- Principal investigator
- Douglas F Nixon
- Funding
- $616K
- Duration
- 2025–2030
Moonbase score
Still being scored
Abstract
Project Abstract The use of cannabis for recreational and medicinal purposes is disproportionately high among people living with HIV-1 (PLWH), with nearly half of cannabis-using PLWH estimated to be at risk for cannabis use disorder. A part of the Single Cell Opioid Responses in the Context of HIV (SCORCH) consortium was formed to address scientific questions about cannabinoids, HIV-1 and antiretroviral therapy (ART) exposure at the single-cell and nuclei level. A significant portion of the human genome consists of repetitive sequences, often called “genomic dark matter” or “junk” DNA of which a large fraction are TEs. Once considered non-functional, TEs are now recognized as key genomic regulators. They can act as promoters, enhancers, and regulators of nearby genes, playing crucial roles in genome evolution and gene regulation. Understanding TE expression at the single-cell level is vital for elucidating their roles in lineage development, cell sub-type identification, and gene regulation. In this application, we propose to harness our newly developed bioinformatic pipeline for single-cell/nuclei transposable element locus level analysis (Stellarscope) and have access to already generated single-cell multiome data as well as new data being generated from 1) a non-human primate model (NHP) of HIV-1 with oral cannabinoid exposure (cannabidiol or Δ9-tetrahydrocannabinol (THC)) and ART , 2) postmortem human brain tissues, and 3) an established human brain organoid model adapted for HIV-1 infection. In two specific aims, we will 1) identify neuronal, glial, and neural stem/progenitor cell TE transcriptional and TE epigenetic gene regulatory states involved in SIV, ART, and cannabinoids in neurogenic regions of the NHP model; 2) identify TE expression of cannabinoid and SIV- relevant cell types and neurogenic brain regions in which SIV and cannabinoids interact to induce anti-inflammatory and neuroprotective cell states; validate HIV-1 and cannabinoid-related cell-type and TE transcriptional changes in a human brain organoid model adapted for HIV- 1 infection. Collectively, these studies will determine the role of TEs in dysregulation of neuroinflammation and neuronal transcriptional and epigenetic dysfunction in the context of HIV-1 infection and cannabinoid use.
Research team
- Michael Jay CorleyPI
- Lishomwa C NdhlovuPI
- Douglas F NixonPI
LOADING MOONBASE SCORE
Questions for FEINSTEIN INSTITUTE FOR MEDICAL RESEARCH
Answered by the team behind this research.
No questions yet. Sign in to ask the first one
Related grants
Same researchers, same institution, same topic, scored first.
- NIH · Oregon Health & Science UniversityNot yet scored
Characterization of Allogeneic T Cells Mediating HIV Cure
Lishomwa C Ndhlovu · $1.7M · 2025–2030
- NIH · Yale UniversityNot yet scored
Effects of Medication for Opioid Use Disorder on Microglial Activation and Neurocognition in People Living with HIV
Michael Jay Corley · $1.2M · 2024–2029
- NIH · VitalantNot yet scored
Modulation of Galectin-9 to Target HIV Persistence
Lishomwa C Ndhlovu · $828K · 2024–2029